A study in nonhuman primates by researchers at the University of Massachusetts and the University of Maryland School of Medicine has shown that the breast cancer drug letrozole has adverse effects on the brain. Letrozole is an aromatase inhibitor (AI) that is often given as adjuvant therapy to women with estrogen receptor-dependent breast cancer, but […]
The post Breast Cancer Drug Shown to Impair Brain Function appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Breast Cancer Drug Shown to Impair Brain Function